Table 2.
Statement | Yes or correct response, N (%) | No or incorrect response, N (%) | Unsure N (%) |
Were you aware that China carries out the programme of quality and efficacy consistency evaluation of generic drugs? | 2118 (92.4) | 74 (3.2) | 99 (4.3) |
Were you aware of the logo ‘Have passed the Consistency Evaluation’ on the generic products? | 1718 (75.0) | 320 (14.0) | 253 (11.0) |
True/false: in principle, the method of bioequivalence tests in vivo is used for consistency evaluation. The standard of bioequivalence is that the 90% CI of the geometric mean experiment/ reference ratios for main pharmacokinetic parameters (Cmax and AUC) falls entirely within the range of 90.00%~120.00%. | 225 (9.8) | 1666 (72.7) | 400 (17.5) |
Were you aware that all the generic drugs in national centralised procurement have passed the consistency evaluation of quality and efficacy? | 2067 (90.2) | 68 (3.0) | 156 (6.8) |
True/false: the generic drugs in the national centralised procurement have the same active ingredients, dosage forms, routes of administration and therapeutic effects with the brand drugs. | 2078 (90.7) | 57 (2.5) | 156 (6.8) |
AUC, area under concentration-time curve; Cmax, peak concentration.